Peijia Medical Limited (HKG:9996)

Hong Kong · Delayed Price · Currency is HKD

7.09

-0.01 (-0.14%)

Apr 20, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Neurointerventional Business	422.78M	355.55M	255.56M	143.52M	94.59M
Neurointerventional Business Growth	18.91%	39.13%	78.06%	51.73%	144.71%
Transcatheter Valve Therapeutic Business	290.09M	259.94M	185.57M	107.31M	41.94M
Transcatheter Valve Therapeutic Business Growth	11.60%	40.07%	72.93%	155.86%	-
Total	712.87M	615.48M	441.13M	250.83M	136.53M
Total Growth	15.82%	39.53%	75.86%	83.71%	253.21%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	712.87M	615.48M	441.13M	250.83M	136.53M
China Growth	15.82%	39.53%	75.86%	83.71%	253.21%
Total	712.87M	615.48M	441.13M	250.83M	136.53M
Total Growth	15.82%	39.53%	75.86%	83.71%	253.21%

Source: S&P Global Market Intelligence.